Melanoma News and Research RSS Feed - Melanoma News and Research

Melanoma is a form of cancer that begins in melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but can also begin in other pigmented tissues, such as in the eye or in the intestines.
Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine. [More]
Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs. [More]
Researchers find priority targets for ovarian cancer immunotherapy

Researchers find priority targets for ovarian cancer immunotherapy

Researchers at Roswell Park Cancer Institute (RPCI) have found that the expression pattern of a unique class of tumor-associated antigens, known as the MAGE cancer-testis antigens (CTAs), correlates with clinical outcome in epithelial ovarian cancer. [More]
Novogen declares shareholder meeting results

Novogen declares shareholder meeting results

Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia. [More]
Research report on the global non-melanoma skin cancer market

Research report on the global non-melanoma skin cancer market

Reportlinker.com announces that a new market research report is available in its catalogue: Global Non-melanoma Skin Cancer Market 2014-2018 [More]
Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, scientists will report here today. [More]
Researchers discover how arginine starvation specifically kills cancer cells

Researchers discover how arginine starvation specifically kills cancer cells

Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells. [More]
Novogen receives funding support to commence studies in muscular dystrophy

Novogen receives funding support to commence studies in muscular dystrophy

The Australian biotechnology company, Novogen Limited today announced receipt of funding from the FSHD Global Research Foundation as part of the Company’s efforts to find effective treatments for a range of musculo-degenerative diseases including facioscapulohumeral dystrophy (FSHD). [More]
Cancer cells that break away from tumors may prefer to settle into soft bed

Cancer cells that break away from tumors may prefer to settle into soft bed

Cancer cells that break away from tumors to go looking for a new home may prefer to settle into a soft bed, according to new findings from researchers at the University of Illinois. [More]
Hand-held photoacoustic microscopy may change the way doctors treat, diagnose melanoma

Hand-held photoacoustic microscopy may change the way doctors treat, diagnose melanoma

A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis. [More]
New probe can be used in 3 unique ways to detect cancer

New probe can be used in 3 unique ways to detect cancer

As thousands of vacationers hit the beach this summer, many of them will expose their unprotected bare limbs to direct UV sunlight, potentially putting them at risk of skin cancer later in life. [More]
Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD). [More]
9.3% of U.S. cancer survivors are current smokers, shows study

9.3% of U.S. cancer survivors are current smokers, shows study

Nine years after diagnosis, 9.3 percent of U.S. cancer survivors were current smokers and 83 percent of these individuals were daily smokers who averaged 14.7 cigarettes per day, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR). [More]
Genetic testing in melanoma: an interview with Dr. Diane McDowell, US Medical Affairs Lead, Oncology, GSK

Genetic testing in melanoma: an interview with Dr. Diane McDowell, US Medical Affairs Lead, Oncology, GSK

Genetic testing, the commonly used process of looking for changes in a person's genes or chromosomes that may be associated with specific diseases or conditions, dates back to before President Richard Nixon declared the War on Cancer with the passage of the National Cancer Act in 1971. [More]
New clinical trial tests use of gold nanoparticles for treating solid tumors in dogs and cats

New clinical trial tests use of gold nanoparticles for treating solid tumors in dogs and cats

When Michael and Sandra Friedlander first came to the Virginia-Maryland College of Veterinary Medicine three years ago with their dog, Grayton, they learned some bad news: Grayton had nasal adenocarcinoma, a form of cancer with a short life expectancy. [More]
Johns Hopkins Medicine, Kaiser Permanente partner to expand ways to deliver quality care

Johns Hopkins Medicine, Kaiser Permanente partner to expand ways to deliver quality care

Kaiser Permanente and Johns Hopkins Medicine today announced plans to strengthen the successful collaboration between the two health care organizations. [More]
EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1). [More]
University of Bradford researchers devise simple blood test to diagnose cancer

University of Bradford researchers devise simple blood test to diagnose cancer

Researchers from the University of Bradford, UK, have devised a simple blood test that can be used to diagnose whether people have cancer or not. [More]
CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil. [More]
Amgen declares share dividend for third quarter 2014

Amgen declares share dividend for third quarter 2014

Amgen announced that its Board of Directors today declared a $0.61 per share dividend for the third quarter of 2014. [More]